CRISPR used to improve red blood cell transfusion compatibility – Drug Target Review
Drug Target Review |
CRISPR used to improve red blood cell transfusion compatibility
Drug Target Review Using CRISPR-Cas9 mediated gene editing, the team of scientists based at the NIHR Blood and Transplant Research Unit (NIHR BTRU) in red cell products, BrisSynBio Centre and NHS Blood and Transplant in Bristol created individual cell lines in which … |
